Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
04/2007
04/04/2007CN1942448A Novel imidazoles
04/04/2007CN1942447A Ion channel modulators
04/04/2007CN1942436A Lysine based compounds
04/04/2007CN1942434A Indene derivatives and process for the preparation thereof
04/04/2007CN1942186A Pyrrolidine compounds
04/04/2007CN1307971C Antimycotic nail varnish composition
04/03/2007US7199146 Imidazolidinedione analogs useful as anticoagulants and antithrombotics
04/03/2007US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
04/03/2007US7199126 P38 MAP kinase; enzyme inhibitors; antiinflammatory agents; cardiovascular disorders
04/03/2007US7199075 Organometallic complexes that comprise bidentate chelating ligands that combine a nitrogen-containing heterocyclic compound with an alcohol and their use for catalyzing the oligomerization of olefins
04/03/2007CA2288140C Farnesyltransferase inhibiting quinazolinones
04/03/2007CA2172519C Method of resolution of two enantiomers by crystallysation
03/2007
03/29/2007WO2007034326A2 Imidazole compounds for the treatment of neurological disorders
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007034035A1 Sulphonamide derivatives
03/29/2007WO2007005174A3 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists
03/29/2007WO2005092066A8 Imidazole compounds
03/29/2007US20070072929 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 4-[(aminocarbonothioyl)amino]-4-oxobutanoate;potententiation; anaerobic/ aerobic microoraganisms; grampositive,gramnegative bacteria; Campylobacter; respiratory system disorders; paraciticides; nontoxic; enzymers/hydrolases/;enzyme inhibitors
03/29/2007US20070072925 Amino-5-[4-(difluoromehtoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
03/29/2007US20070072915 Novel phenoxyacetamide derivative and use thereof for preparation of diphenylamines
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007CA2622086A1 Sulphonamide derivatives
03/29/2007CA2619068A1 Imidazole compounds for the treatment of neurological disorders
03/28/2007EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
03/28/2007EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/28/2007EP1765793A1 Cetp inhibitors
03/28/2007EP1765789A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
03/28/2007EP1765773A2 Amino, amino acid or peptide conjugates of retinoic acid
03/28/2007EP1470136B1 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
03/28/2007CN1938282A Imidazol derivatives as tyrosine kinase inhibitors
03/28/2007CN1938281A Ion channel modulators
03/28/2007CN1938280A Thiourea compositions and uses thereof
03/28/2007CN1938279A Modulators of atp-binding cassette transporters
03/28/2007CN1938022A Ion channel modulators
03/28/2007CN1938021A Ion channel modulators
03/28/2007CN1938020A Ion channel modulators
03/28/2007CN1935829A Nucleic acid hydrolysis cutting agent based on cucurbituril
03/28/2007CN1935704A Method for treating condensation waste water for producing imidacloprid and resourcized recovering its imidazolidine
03/28/2007CN1307163C Imidazole aromatic alcohol derivatives and preparation and use thereof
03/28/2007CN1307162C Halogen-free ionic liquids
03/28/2007CN1307159C TNF-alpha prodn. inhibitors
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents
03/27/2007US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196084 Cdc25 phosphatase inhibitors
03/27/2007US7195772 Amino-acid iodine complex
03/22/2007WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007WO2007032536A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder
03/22/2007WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c
03/22/2007WO2007031721A1 Midazole-4-carboxamide derivatives for use as cb modulators
03/22/2007WO2007031720A1 1,2-diarylimidazoles for use as cbi modulators
03/22/2007WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors
03/22/2007US20070066822 Ionic liquids
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments
03/22/2007CA2622597A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder
03/22/2007CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007CA2621408A1 1,2-diarylimidazoles for use as cb1 modulators
03/22/2007CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c
03/21/2007EP1764365A1 A process for the preparation of sartan derivates and intermediates useful in such process
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide
03/21/2007EP1763511A1 Phenoxyacetic acid derivatives as ppar agonists
03/21/2007EP1763382A1 2-oxy-acetamide compound, the uses thereof and compositions for stimulating or inducing the growth, and/or retarding the loss, of keratin fibres
03/21/2007EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
03/21/2007EP0865446B1 Agents for promoting bone formation
03/21/2007CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders
03/21/2007CN1934090A Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
03/21/2007CN1934087A Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of T cells and/or keratinocytes
03/21/2007CN1931889A Modified solid imidazole curing agent and its modification process
03/21/2007CN1931857A Prepn process of 5-losartan carboxylate
03/21/2007CN1931845A Alkaline ionic liquid and its prepn process and application
03/21/2007CN1305859C Preparation method of methylol hydantoin composite with low content of free formaldehyde
03/21/2007CN1305846C Novel urea derivatives
03/20/2007US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192954 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives
03/20/2007US7192940 Ether compounds
03/20/2007CA2278509C Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof
03/15/2007WO2007029587A1 β SECRETASE INHIBITOR
03/15/2007WO2007029267A1 Process for industrially viable preparation of imidapril hydrochloride
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2006055922A8 Anthranilamide insecticides
03/15/2007US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
03/15/2007US20070060662 Polymerisation initiator system
03/15/2007US20070060587 Indane derivates as muscarinic receptor agonists
03/15/2007US20070060584 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/14/2007EP1761531A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders
03/14/2007EP1761503A2 Imidazol derivatives as tyrosine kinase inhibitors
03/14/2007EP1526917B1 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
03/14/2007CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
03/14/2007CN1930143A MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
03/14/2007CN1930132A Ion channel modulators
03/14/2007CN1927848A Substituted acid compounds, preparation method and medicament use thereof
03/14/2007CN1927842A Synthesis technology of 1,3-dimethyl-2-chloroimidazoline chloride
03/14/2007CN1304403C Monophosphine ligand having C2 symmetric skeleton, synthesis method and application